Ezetimibe ameliorates cardiovascular complications and hepatic steatosis in obese and type 2 diabetic db/db mice

The Journal of Pharmacology and Experimental Therapeutics
Masaya FukudaShokei Kim-Mitsuyama

Abstract

Type 2 diabetes plays a major role in the development of cardiovascular diseases. The present study was undertaken to investigate the effect of ezetimibe, a potent cholesterol absorption inhibitor, on cardiovascular injury of obese and type 2 diabetic db/db mice. Diabetic db/db mice fed a Western diet were given ezetimibe for 9 weeks, and the effects on cardiovascular injury and hepatic steatosis were examined. Ezetimibe treatment of db/db mice significantly improved vascular endothelial function, which was associated with the restoration of the decreased phospho-Akt and phospho-endothelial nitric-oxide synthase (eNOS). Moreover, ezetimibe also reduced vascular superoxide levels in db/db mice, accompanied by the attenuation of NADPH oxidase subunit gp91(phox) and Nox4 and the prevention of down-regulation of Cu/Zn-superoxide dismutase (SOD) and extracellular SOD. Thus, the improvement of vascular endothelial function by ezetimibe in diabetic mice seems to be attributed to the improvement of eNOS function and the attenuation of oxidative stress. Ezetimibe treatment also significantly attenuated cardiac interstitial fibrosis and coronary arterial thickening of diabetic mice and ameliorated cardiac macrophage infiltration. This im...Continue Reading

References

Jan 1, 1982·Diabetes·D L Coleman
Mar 17, 2000·Circulation Research·K K GriendlingM Ushio-Fukai
Dec 18, 2001·Arteriosclerosis, Thrombosis, and Vascular Biology·H R DavisG Tetzloff
Aug 2, 2002·The New England Journal of Medicine·Satish KenchaiahRamachandran S Vasan
Jun 2, 2005·Proceedings of the National Academy of Sciences of the United States of America·Margarita Garcia-CalvoNancy A Thornberry
Dec 15, 2006·Nature·Luc F Van GaalChristophe E De Block
Dec 16, 2006·Arteriosclerosis, Thrombosis, and Vascular Biology·Eiichiro YamamotoShokei Kim-Mitsuyama
Jun 16, 2007·The Journal of Clinical Investigation·Ryan E TemelLiqing Yu
Oct 13, 2007·Arteriosclerosis, Thrombosis, and Vascular Biology·Eiichiro YamamotoShokei Kim-Mitsuyama
Mar 11, 2008·European Journal of Pharmacology·Shuqin ZhengJoyce J Hwa
Jul 8, 2008·Atherosclerosis·Hironori NakagamiRyuichi Morishita

❮ Previous
Next ❯

Citations

May 31, 2012·Current Diabetes Reports·Anil Karihaloo
Oct 26, 2011·Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre·Kazuhiko KotaniNobuyuki Taniguchi
Oct 29, 2010·BMC Medical Genomics·Junguk HurEva L Feldman
Oct 27, 2011·Journal of Atherosclerosis and Thrombosis·Hirotsugu KurobeTetsuya Kitagawa
Jun 1, 2014·Translational Research : the Journal of Laboratory and Clinical Medicine·Michele CavaleraNikolaos G Frangogiannis
Dec 20, 2011·Pharmacological Reports : PR·Kazuhiko KotaniAlejandro Gugliucci
Dec 26, 2015·Journal of Molecular and Cellular Cardiology·Ilaria Russo, Nikolaos G Frangogiannis
Oct 10, 2014·British Journal of Pharmacology·O PechánováP Ferdinandy
Aug 31, 2013·Diabetes & Metabolism Journal·Sung-Woo Park
Feb 22, 2012·American Journal of Physiology. Gastrointestinal and Liver Physiology·Mark NaplesKhosrow Adeli
Feb 26, 2020·Antioxidants·Anne D HafstadEllen Aasum
Jul 15, 2015·World Journal of Gastroenterology : WJG·Eugene ChangCheol-Young Park
Dec 31, 2020·Biochimica Et Biophysica Acta. Molecular Basis of Disease·Izabela Tuleta, Nikolaos G Frangogiannis
Apr 29, 2021·Free Radical Biology & Medicine·Nikole J ByrneHeiko Bugger
Aug 1, 2021·Advanced Drug Delivery Reviews·Izabela Tuleta, Nikolaos G Frangogiannis
May 6, 2021·Physiological Reviews·Jun RenYingmei Zhang
May 13, 2011·Current Opinion in Lipidology

❮ Previous
Next ❯

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.